127 related articles for article (PubMed ID: 38380957)
21. m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway.
Lin K; Zhou E; Shi T; Zhang S; Zhang J; Zheng Z; Pan Y; Gao W; Yu Y
J Exp Clin Cancer Res; 2023 Aug; 42(1):217. PubMed ID: 37605223
[TBL] [Abstract][Full Text] [Related]
22. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
[TBL] [Abstract][Full Text] [Related]
23. FTO regulates myoblast proliferation by controlling CCND1 expression in an m
Deng K; Zhang Z; Ren C; Liang Y; Gao X; Fan Y; Wang F
Exp Cell Res; 2021 Apr; 401(2):112524. PubMed ID: 33651996
[TBL] [Abstract][Full Text] [Related]
24. LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/BRD4 axis.
Fu Y; Liu L; Wu H; Zheng Y; Zhan H; Li L
Mol Cell Biochem; 2024 Mar; 479(3):553-566. PubMed ID: 37120495
[TBL] [Abstract][Full Text] [Related]
25. N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2.
Zhou L; Han X; Li W; Wang N; Yao L; Zhao Y; Zhang L
Reprod Sci; 2022 Apr; 29(4):1305-1315. PubMed ID: 34254281
[TBL] [Abstract][Full Text] [Related]
26. The N6-methyladenosine demethylase FTO is required for odontoblast differentiation in vitro and dentine formation in mice by promoting RUNX2 exon 5 inclusion through RBM4.
Xu M; Li B; Huang J; Jia R; Guo J
Int Endod J; 2023 Dec; 56(12):1534-1549. PubMed ID: 37698901
[TBL] [Abstract][Full Text] [Related]
27. Long non‑coding RNA SNHG20 promotes cell proliferation, migration and invasion in retinoblastoma via the miR‑335‑5p/E2F3 axis.
Song J; Zhang Z
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080033
[TBL] [Abstract][Full Text] [Related]
28. FTO promotes the progression of cervical cancer by regulating the N6-methyladenosine modification of ZEB1 and Myc.
Wang A; Jin C; Wang Y; Yu J; Wang R; Tian X
Mol Carcinog; 2023 Aug; 62(8):1228-1237. PubMed ID: 37306026
[TBL] [Abstract][Full Text] [Related]
29. N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer.
Wu J; Wang X; Li X
Epigenomics; 2022 Dec; 14(23):1509-1522. PubMed ID: 36815224
[TBL] [Abstract][Full Text] [Related]
30. N6-methyladenosine demethyltransferase FTO-mediated autophagy in malignant development of oral squamous cell carcinoma.
Wang F; Liao Y; Zhang M; Zhu Y; Wang W; Cai H; Liang J; Song F; Hou C; Huang S; Zhang Y; Wang C; Hou J
Oncogene; 2021 Jun; 40(22):3885-3898. PubMed ID: 33972683
[TBL] [Abstract][Full Text] [Related]
31. FTO inhibits oxidative stress by mediating m6A demethylation of Nrf2 to alleviate cerebral ischemia/reperfusion injury.
Hou L; Li S; Li S; Wang R; Zhao M; Liu X
J Physiol Biochem; 2023 Feb; 79(1):133-146. PubMed ID: 36327034
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of FTO alleviates osteoarthritis by regulating the processing of miR-515-5p and the TLR4/MyD88/NF-κB axis.
Cai D; Zhang J; Yang J; Lv Q; Zhong C
Int Immunopharmacol; 2023 Jan; 114():109524. PubMed ID: 36538851
[TBL] [Abstract][Full Text] [Related]
33. Decreased
Luo Q; Gao Y; Zhang L; Rao J; Guo Y; Huang Z; Li J
Biomed Res Int; 2020; 2020():5735279. PubMed ID: 32884942
[TBL] [Abstract][Full Text] [Related]
34. HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer.
Yang Z; Jiang X; Zhang Z; Zhao Z; Xing W; Liu Y; Jiang X; Zhao H
Cancer Gene Ther; 2021 Feb; 28(1-2):141-155. PubMed ID: 32655129
[TBL] [Abstract][Full Text] [Related]
35. FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21/Nrf2 activation in a HuR-dependent m6A manner.
Yang Y; Ren J; Zhang J; Shi H; Wang J; Yan Y
Redox Biol; 2024 Apr; 70():103067. PubMed ID: 38316068
[TBL] [Abstract][Full Text] [Related]
36. Increased N6-methyladenosine causes infertility is associated with FTO expression.
Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
[TBL] [Abstract][Full Text] [Related]
37. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
38. SUMOylation modification of FTO facilitates oxidative damage response of arsenic by IGF2BP3 in an m6A-dependent manner.
Zhang H; Chen Q; Han H; Guo C; Jiang X; Xia Y; Zhang Y; Zhou L; Zhang J; Tian X; Mao L; Qiu J; Zou Z; Chen C
J Hazard Mater; 2024 Jul; 472():134440. PubMed ID: 38723480
[TBL] [Abstract][Full Text] [Related]
39. FTO-Nrf2 axis regulates bisphenol F-induced leydig cell toxicity in an m6A-YTHDF2-dependent manner.
Zhou SM; Li JZ; Chen HQ; Zeng Y; Yuan WB; Shi Y; Wang N; Fan J; Zhang Z; Xu Y; Cao J; Liu WB
Environ Pollut; 2023 May; 325():121393. PubMed ID: 36878272
[TBL] [Abstract][Full Text] [Related]
40. FTO-Dependent N
Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
